The program offers eligible Medicare beneficiaries access to certain FDA-approved GLP-1 medications for chronic weight management at a predictable monthly cost
However, if you experience any of the following, consult your healthcare provider: Persistent vomiting leading to dehydration Severe abdominal pain Symptoms of pancreatitis (intense stomach pain, nausea, and vomiting) Unintended and excessive weight loss FAQs Why do GLP-1 medications cause nausea
Individuals seeking sustainable weight loss solutions
Faced with a high-cost drug class hitting an optional budget line item, state Medicaid agencies were likely compelled to prioritize the immediate financial stability of the entire program
Analysts predicted the move would revive the struggling diet giant, but the stock has since plummeted more than 90% as the hype collapsed
GLP-1s (commercially known as Wegovy and Ozempic) have opened options for those who have struggled with weight loss
